Sun Pharmaceutical Industries, an international, integrated, speciality pharmaceutical company, witnessed a sharp fall in share price on Tuesday after Japan's Daiichi Sankyo started selling its stake in the Indian drug maker.

Daiichi Sankyo has sold its its entire 8.9% stake via multiple blocks at between Rs 330-960 a share (lower end of the band).

Daiichi has raised USD 3 billion via stake sale in Sun Pharma. Daiichi had obtained around 9% stake in Sun Pharma following the merger of Ranbaxy with the Indian pharma major.

Shares of the company are trading at Rs 943.75, down Rs 100.35, or 9.61% at the Bombay Stock Exchange (BSE) on Tuesday at 11:17 a.m.

The scrip has touched an intra-day high of Rs 976.15 and low of Rs 933.10. The total volume of shares traded at the BSE is 8,929,495.